Market
Highlights:
The portfolio
of pharmaceutical companies has become more diversified in recent years with
the arrival of nanotechnology, tissue regeneration, and stem cell research.
These new products need a process of manufacture and distribution need to be
safer than conventional chemical molecules by their intrinsic characteristics.
In addition, the substantial growth of emerging markets, the environmental
pressures for sustainable progress and the growing scrutiny by regulatory
authorities (new regulations, broader risk management, etc.) back the idea that
a new approach to manufacturing and distribution would be needed in future
years to meet the needs of the coming future.
The Global Blockchain In Pharmaceutical Supply Chain
Management Market is expected to register an
approximate CAGR of 22.5% during the forecast period of
2019–2024.
Key Players:
·
IBM
·
Microsoft
·
SAP SE
·
Oracle
·
Tibco Software
·
Auxesis Group
·
Omnichain
·
Vechain Foundation
·
Chainvine
·
Applied Blockchain
·
AWS
·
Huawei
·
Guardtime
Segmentation:
The global
blockchain in pharmaceutical supply chain management is segmented on the basis
of application, end user, and region.
On the basis
of application, the global blockchain in pharmaceutical supply chain management
market is segmented into product traceability,
risk and compliance management, payment & settlement, others. The
market by end user is segmented into manufacturers, distributors,
healthcare providers
On the bases
of region, the global blockchain in pharmaceutical supply chain management market
is segmented into the Americas, Europe, Asia-Pacific, and the Middle East &
Africa. The Americas is expected to hold the largest market share and the
Middle East & Africa with a low market share during the forecasted period.
Regional
Analysis:
The healthcare
sector and its supporting IT infrastructure are going through dramatic changes,
all of which impact the claims management process and lead to improving the
technology. Many healthcare organizations use robotic process automation,
intelligent EDI integration, insurance discovery, and patient solutions all
within their workflow platform to dramatically enhance the overall process. The
adoption of various software has increased profit.
Infrastructure
and technology are continuously evolving in developing regions such as
Asia-Pacific. A number of different multinational and local companies are
involved in developing their markets in this region owing to the developing
economy and increasing government support. An increasing number of healthcare
companies have provided a good opportunity for the development of the
blockchain in pharmaceutical supply chain management market.
Furthermore,
in the United States, the Drugs Quality and Safety Act (DQSA) was promoted by
Congress on November 27, 2013. This outlines the steps to be taken to develop
an interoperable electronic supply chain management system. This will
strengthen the FDA's capability to protect consumers from exposure to drugs
that could be fake or from the black market.
No comments:
Post a Comment